Cardiac Drug Development Guide - Pugsley, Michael K.; SpringerLink (Online service) (Totowa, NJ : Humana Press : Imprint: Humana, 2003)
Cardiac Drug Development -- Novel Molecular Targets for Cardiac Drug Development -- The Role of Cardiac Pacemaker Currents in Antiarrhythmic Drug Discovery -- Oxygen Free Radicals in Heart Disease -- Mitogen-Activated Protein Kinases-Mediated Signaling in Cardiac Pathology -- Development of Anti-Inflammatory Drugs for Cardiovascular Disease -- Development and Use of Platelet Glycoprotein Antagonists in Heart Disease -- The Sodium-Hydrogen Exchange System in the Heart -- Nitric Oxide and Cardiac Ischemia -- Functional Endpoints Evaluating Cardiac Drug Activity -- Ionic Mechanisms of Atrial Fibrillation -- Targeting Ischemic Ventricular Arrhythmias -- Biochemical Mediators of Ventricular Arrhythmias in Ischemic Heart Disease -- Heterologous Expression Systems and Screening Technologies in Ion Channel Drug Discovery -- Molecular Diversity of Ion Channels in the Mouse Heart -- Delayed Protection of the Myocardium -- Clinical Aspects in Cardiac Drug Development -- Cardiac Troponin Testing for Detection of Myocardial Infarction -- A Genetic Basis for Cardiac Arrhythmias -- Myocardial Adenoviral Vector Delivery for Cardiovascular Gene Therapy -- The Role of Pharmacometrics in Cardiovascular Drug Development -- Gender Differences in Heart Failure -- Angiogenesis Therapies for Coronary Artery Disease.
Keywords: Pharmacy; Pharmacy